4//SEC Filing
Jellison William R 4
Accession 0001171843-25-004069
CIK 0000898437other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 5:12 PM ET
Size
6.1 KB
Accession
0001171843-25-004069
Insider Transaction Report
Form 4
JELLISON WILLIAM R
Director
Transactions
- Award
Common Stock
2025-06-20+14,164→ 20,403 total
Holdings
- 2,700(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026.
- [F2]Consists of shares transferred by Mr. Jellison to the Amended and Restated William R. Jellison Trust dated July 3, 2018, of which Mr. Jellison is a beneficiary and trustee.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001189883
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 5:12 PM ET
- Size
- 6.1 KB